Embio Limited

Home
Products
CDMO

Overview

2003

Established
API and CDMO

Focus
DSIR, IBSC,
ISO 9001:2015

Certifications
~61

Employees
23 (10)

Process
patents filed
(commercialized)

Technical skillsets

Upstream process development, scale up and high cell density fermentation
Whole cell biotransformation in yeast and bacteria
Downstream processing using chromatography including adsorption, ion exchange, gel filtration
Full fledged organic chemistry division for substrate synthesis and semisynthetic derivative preparations
Dedicated analytical development lab for method development and validation

Core capabilities

Process capabilities

In-house development of GMO based biotransformation processes
Enhanced biotransformation capabilities through genetically engineered strains
Experience in downstream processing using chromatography
Undertaken multiple CRO/CDMO projects in GMOs

Production capabilities

Biotransformation capability from 10L up to 40 KL
Integration of chemistry & biotechnology for semisynthetic operations
3 stage efficient effluent treatment (Bioreactor, RO system & MEE)
Pilot plant for biotech & chemistry divisions

Support capabilities

Functional IBSC-DSIR recognised lab with biosafety framework
Think tanks access for Embio –IITB,UICT, BATU
Synergy with Organic chemistry division for any subsequent transformations
Analytical division equipped to meet method development or analytical needs.

Lab scale infrastructureRead More

Pilot scale infrastructureRead More

Commercial scale infrastructureRead More

CDMO offerings

Get in touch

Corporate Office

Marketing / Sales

Production Plants

HR

CDMO